638
Views
48
CrossRef citations to date
0
Altmetric
Research Articles

Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson’s disease

, &
Pages 142-150 | Received 31 Mar 2016, Accepted 15 Aug 2016, Published online: 01 Sep 2016

References

  • Costantino HR, Illum L, Brandt G, et al. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm 2007;33:1–24.
  • Byeongmoon J, Anna G. Lessons from nature: stimuli-responsive polymers and their biomedical applications. Trends Biotechnol 2002;20:305–11.
  • Ugwoke M, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 2001;53:3–22.
  • Hanson LR, et al. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agent to central nervous system and treat neurodegenerative disease. BMC Neuro Sci 2008;9:55–61.
  • Kadam SS, Mahadik KR. In situ gelling systems: a promising approach for transdermal drug delivery. The East Pharm 1994;4:32–50.
  • Jadhav KR, Gambhire MN Shaikh IM, et.al. Nasal drug delivery system-factors affecting and applications. Curr Drug Ther 2007;2:27–38.
  • Banks W. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol 2009;9:1–5.
  • Mainardes RM, Khalil NM, Gremiao MPD. Intranasal delivery of Zidovudine by PLA and PLA-PEG blend nanoparticles. Int J Pharm 2010;395:266–71.
  • Wang J, Tabata Y, Morimoto K. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of Ex vivo release and in vivo insulin absorption in rat. J Control Rel 2001;11:1–37.
  • Dahlin M, Bergman U, Jansson B, Bjork E. Transfer of dopamine in the olfactory pathway following nasal administration in mice. Pharm Res 2000;17:737–42.
  • Sharma S, Lohan S, Murthy S. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery. Drug Dev Ind Pharm 2014;40:869–78.
  • Corbo DC, Liu JC, Chien YW. Nasal delivery of progestational steroid ovariectomized rabbits: I progesteron–comparison of pharmacokinetic with intravenous and oral administration. Int J Pharm 1988;46:133–40.
  • Patel HK, Suthar RM, Patal SR. Nasal drug delivery system for targeting to brain. Int J Pharm Innovat 2011;1:1–11.
  • Upadhyay S, Parikh A, Joshi P, et al. Intranasal drug delivery system – a glimpse to become maestro. J Appl Pharma Sci 2011;01:34–44.
  • Bromberg LE, Ron ES. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv Drug Deliv Rev 1998;31:197–221.
  • Edsman K, Carlfors J, Petersson R. Rheological evaluation of poloxamer as an In situ gel for ophthalmic use. Eur J Pharm Sci 1998;6:105–12.
  • Rao M, Warrier DU, Gaikwad SR, et al. Phosphorylation of psyllium seed polysaccharide and its characterization. Int J Bio Mac 2016;85:315–26.
  • Prajapti N, Goyal A. Thermoreversible mucoadhesive gel: a review. Int J Innov Drug Discov 2013;3:67–84.
  • Debra JT, Deborah V. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease. Clin Therapeu 2007;29:2654–66.
  • Jafarieh O, Md S, Ali M, et al. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting. Drug Dev Ind Pharm 2015;41:1674–81.
  • Trond K, John H, Ingebrigt S. Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem 2008;8:1049–67.
  • Schmolka IR. Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 1992;6:571–82.
  • Liu Y, Zhu Y, Wei G, Lu W. Effect of carrageenan on poloxamer-based In situ gel for vaginal use: improved in vitro and in vivo sustained-release properties. Eur J Pharm Sci 2009;37:306–12.
  • Zhang X, Zhou R, Zhang J. A novel thermo-responsive drug delivery system with positive controlled release. Int J Pharm 2002;235:43–50.
  • Zaki NM, Awada GA, Mortada ND, Hady SS. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive In situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 2007;32:296–307.
  • Gilbert J, Hadgraft J, Bye A, Brookes L. Drug release from Pluronic F-127 gels. Int J Pharm 1986;32:223–8.
  • Vadnere M, Amidon G, Lindenbaum S, Haslam JE. Thermodynamic studies on the gel–sol transition of some pluronic polyols. Int J Pharm 1984;22:207–18.
  • Alsarra IA. Mucoadhesive polymeric hydrogels for nasal delivery of acyclovir. Drug Dev Ind Pharm 2009;35:352–62.
  • Yong CS, Choi JS, Quan Q, Rhee J. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int J Pharm 2009;275:195–205.
  • Pagar S, Shinkar DM, Saudagar RB. Design, development and evaluation of in situ nasal mucoadhesive gel of metaprolol succinate by using guar gum as natural mucoadhesive polymer. Int J Pharm Sci Rev Res 2014;19:46–52.
  • Zhao Y, Yue P, Tao T, Chen Q. Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats. Acta Pharmacol Sin 2007;28:273–8.
  • Martinac A, Filipovic-Gricc J, Voinovich D, et al. Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery. Int J Pharm 2005;291:69–77.
  • Kothapalli L, Choudhari M, Thomas A, et al. Validated RP-HPLC and spectrophotometric determination of Ropinirole hydrochloride in bulk and in pharmaceutical dosage form. Der Pharma Chemical 2012;4:574–80.
  • Hatefi A, Amsden B. Biodegradable injectable in situ forming drug delivery systems. J Control Release 2002;80:9–28.
  • Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002;54:37–51.
  • Kono K. Thermosensitive polymer-modified liposomes. Adv Drug Deliv Rev 2001;53:307–19.
  • Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm 2000;50:27–46.
  • Robert CR, Buri PA, Peppas NA. Experimental method for bioadhesive testing of various polymers. Acta Pharm Technol 1988;34:95–8.
  • Patel AU, Shah PP, Shah PJ, et al. Formulation development and evaluation of thermoreversible In situ gel for asenaphine maleate. Curr Psychopharmacol 2016;3:213–18.
  • Sheri PS, Prasanth VS. Development and evaluation of in situ nasal gel formulations of loratadine. Res Pharma Sci 2015;10:466–76.
  • Yadav D, Kunjwini H, Suryawanshi S. Formulation and evaluation of thermosensitive in situ gel of Salbutamol sulfate for nasal drug delivery system. Int J Pharm Pharm Sci 2012;4:188–94.
  • Dholakia M, Thakkar V, Patel N, Gandhi T. Development and characterization of thermoreversible mucoadhesive moxifloxacin hydrochloride in situ ophthalmic gel. J Pharma Bio Allied Sci 2012;42–5.
  • Bhandwalkar M, Amelia M. Thermoreversible nasal in situ gel of venlafaxine hydrochloride: formulation, characterization, and pharmacodynamic evaluation. AAPS PharmSciTech 2013;14:101–10.
  • Makwana S, Patel V, Parmar S. Development and characterization of insitu gel for opthalmic formulation containing ciprofloxacin hydrochloride. Fluid Res Pharma Sci 2016;6:1–6.
  • Pathan I, Chudiwal V, Farooqui I, Shingare P. Formulation design and evaluation of nasal in situ gel as a novel vehicle for azelastine hydrochloride. Int J Drug Deliv 2013;5:284–90.
  • Zaki NM, Awad GA, Mortada ND, et al. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharma Sci 2007;31:296–307.
  • Tanagi N, Rahul T, Nitin J, et al. Formulation and evaluation of pH induced nasal in-situ gel of Salbutamol sulfate. Int J Pharm Sci Nanotechnol 2008;1:2.
  • Saini R, Saini S, Singh G, et al. In situ gels- a new trends in ophthalmic drug delivery system. Int J Phsrm Sci 2015;6:386–90.
  • Bain MK, Bhowmik M, Ghosh SN, Chattopadhyay D. In-situ fast gelling formulation of methyl cellulose for in-vitro ophthalmic controlled delivery of ketorolac tromethamine. J Appl Polym Sci 2009;113:1241–6.
  • Basu S, Bandopadhya A. Development and characterization of mucoadhesive In situ nasal gel of midazolam prepared with Ficuscarica mucilage. AAPS PharmaSci Tech 2010;11:1223–31.
  • Akhani R, Modi C. Formulation development and evaluation of In situ gel for vaginal and anti fungal drug. Int J Pharm Sci 2014;5:343–64.
  • Washington N, Steele RJ, Jackson SJ, et.al. Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int J Pharm 2000;198:139–46.
  • Patel M, Thakkar H, Kasture PV. Preparation and evaluation of thermoreversible formulates of Flunarizine hydrochloride for nasal delivery. Int J Pharm Pharm Sci 2010;2:116–20.
  • Mall MA. Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models. J Aerosol Med Pulm Drug Deliv 2008;21:13–24.
  • Gilbert JC, Richardson JL, Davies MC, et al. The effect of solutes and polymers on the gelation properties of Pluronic F-127 solutions for controlled drug delivery. J Contr Rel 1987;1:113–18.
  • Miyazaki S, Takeuchi S, Yokouchi C, Takada M. Pluronic F-127 gels as a vehicle for topical administration of anticancer agents. Chem Pharm Bull 1984;32:4205–8.
  • Lenaerts V, Triqueneux C, Quarton M, et al. Temperature-dependent rheological behavior of Pluronic F. Int J Pharm 1987;39:121–7.
  • Jorgensen E, Hvidt S, Brown W, Schillen K. Effects of salts on the micelllization and gelation of triblock copolymer studied by rheology and light scattering. Macromolecules 1997;30:2355–64.
  • Miller SC, Drabik BR. Rheological properties of poloxamer vehicles. Int J Pharm 1984;18:269–76.
  • Attwood D, Collet JH, Tait C. The micellar properties of the poly(oxyethylene)–poly(oxypropylene) copolymer Pluronic F-127 in water and electrolyte solution. Int J Pharm 1985;6:25–33.
  • Uttarwar S. Formulation and development of In situ gelling system for nasal administration for an antiemetic drug ondansetron hydrochloride by using Pluronics 127P and Pluronics 68. Int J Res Pharm Biomed Sci 2012;3:1103–18.
  • Jadhav UG, Dias RJ, Mali KK, Havaldar VD. Development of In situ gelling and mucoadhesive liquid suppository of Ondansetron. Int J Chem Tech Res 2009;1:953–61.
  • Hitendra M, Hannan S, Surendra G, Pankaj N. In situ gelling system based on thiolated Gellan gum as new carrier for nasal administration of dimenhydrinate. Int J Pharm Sci and Nanotech 2009;2:544–50.
  • Beule AG. Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses. Curr Top Otorhinolaryngol Head Neck Surg 2010;9:1–24.
  • Chow HS, et al. Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats. J Pharm Sci 1999;88:754–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.